Archives of Virology

, Volume 138, Issue 1–2, pp 117–134 | Cite as

The S1 glycoprotein but not the N or M proteins of avian infectious bronchitis virus induces protection in vaccinated chickens

  • J. Ignjatovic
  • L. Galli
Original Papers


The S1, N and M proteins, obtained from the nephropathogenic N1/62 strain of infectious bronchitis virus (IBV) by immunoaffinity purification with monoclonal antibodies, were used for immunization of chickens. For all three antigens multiple immunizations were necessary for induction of an antibody response. Protection of chickens vaccinated with the S1 glycoprotein against virulent challenge was demonstrated by the complete absence of virus in tracheas and kidneys of vaccinated chickens. Following four immunizations with the S1 glycoprotein 71% and 86% of chickens were protected at the level of tracheas and kidneys, respectively. Three immunizations with the S1 glycoprotein protected 70% and 10% of chickens at the level of kidney and trachea, respectively. Neither the N nor the M antigen induced protection to a virulent challenge with the nephropathogenic N1/62 strain of IBV after four immunizations. Virus neutralizing, haemagglutination inhibiting and ELISA antibodies were detected in chickens immunized with the S1 glycoprotein and inactivated N1/62 virus, however there was no correlation between the presence of any of these antibodies and protection.


Monoclonal Antibody Infectious Disease Antibody Response Bronchitis Haemagglutination Inhibit 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Barthold SW, Smith AL (1989) Virus strain specificity of challenge immunity to coronavirus. Arch Virol 104: 187–196Google Scholar
  2. 2.
    Boots AMH, Kusters JG, Van Noort JM, Zwaagstra KA, Rijke E, Van Der Zeijst BAM, Hensen EJ (1991) Localization of a T-cell epitope within the nucleocapsid protein of avian coronavirus. Immunology 74: 8–13Google Scholar
  3. 3.
    Boots AMH, Benaissa-Trouw BJ, Hesselink W, Rijke E, Schrier C, Hensen EJ (1992) Induction of anti-viral immune responses by immunization with recombinant-DNA encoded avian coronavirus nucleocapsid protein. Vaccine 10: 119–124Google Scholar
  4. 4.
    Boursnell MEG, Binns MM, Foulds IJ, Brown TDK (1985) Sequences of the nucleocapsid genes from two strains of avian infectious bronchitis virus. J Gen Virol 66: 573–580Google Scholar
  5. 5.
    Cavanagh D (1983) Coronavirus IBV glycopolypeptides: size of their polypeptide moieties and nature of their oligosaccharides. J Gen Virol 64: 1187–1191Google Scholar
  6. 6.
    Cavanagh D (1983) Coronavirus IBV: further evidence that the surface projections are associated with two glycopolypeptides. J Gen Virol 64: 1787–1791Google Scholar
  7. 7.
    Cavanagh D (1983) Coronavirus IBV: structural characterization of the spike protein. J Gen Virol 64: 2577–2583Google Scholar
  8. 8.
    Cavanagh D, Darbyshire JH, Davis P, Peters RW (1984) Induction of humoral neutralising and haemagglutination-inhibiting antibody by the spike protein of avian infectious bronchitis virus. Avian Pathol 13: 573–583Google Scholar
  9. 9.
    Cavanagh D, Davis PJ, Darbyshire JH, Peters RW (1986) Coronavirus IBV: virus retaining spike glycopolypeptide S2 but not S1 is unable to induce virus-neutralizing or haemagglutination-inhibiting antibody, or induce chicken tracheal protection. J Gen Virol 67: 1435–1442Google Scholar
  10. 10.
    Cook JKA, Davison TF, Huggins MB, Mclaughlan P (1991) Effect of in ovo bursectomy on the course of an infectious bronchitis virus infection in line C White Leghorn chickens. Arch Virol 118: 225–234Google Scholar
  11. 11.
    Daniel C, Talbot PJ (1990) Protection from lethal coronavirus infection by affinity-purified spike glycoprotein of murine hepatitis virus, strain A59. Virology 174: 87–94Google Scholar
  12. 12.
    Darbyshire JH, Rowell JG, Cook JKA Peters RW (1979) Taxonomic studies on strains of avian infectious bronchitis virus using neutralisation tests in tracheal organ cultures. Arch Virol 61: 227–238Google Scholar
  13. 13.
    De Diego M, Laviada MD, Ehjuanes L, Escribano JM (1992) Epitope specificity of protective lactogenic immunity against swine transmissible gastroenteritis virus. J Virol 66: 6502–6508Google Scholar
  14. 14.
    De Groot RJ, Van Leen RW, Dalderup MJM, Vennema H, Horzinek MC, Spann WJM (1989) Stably expressed FIPV peplomer protein induces cell fusion and elicits neutralizing antibodies in mice. Virology 171: 493–502Google Scholar
  15. 15.
    Fleming JO, Shubin RA, Sussman MA, Casteel N, Stohlman SA (1989) Monoclonal antibodies to the matrix (E1) glycoprotein of mouse hepatitis virus protect mice from encephalitis. Virology 168: 162–167Google Scholar
  16. 16.
    Hasony HJ, Macnaughton MR (1981) Antigenicity of mouse hepatitis virus strain 3 subcomponents in C57 strain mice. Arch Virol 69: 33–41Google Scholar
  17. 17.
    Homberger FR, Barthold SW (1992) Passively aquired challenge immunity to enterotropic coronavirus in mice. Arch Virol 126: 35–43Google Scholar
  18. 18.
    Ignjatovic J, Mcwaters PG (1991) Monoclonal antibodies to three structural proteins of avian infectious bronchitis virus: characterization of epitopes and antigenic differentiation of Australian strains. J Gen Virol 72: 2915–2922Google Scholar
  19. 19.
    King DJ, Cavanagh D (1991) Infectious bronchitis. In: Calnek BW, Barnes HJ, Beard CW, Reid WM, Yoder HW Jr (eds) Diseases of poultry, 9th edn. Iowa State University Press, Ames, pp 471–484Google Scholar
  20. 20.
    Koch G, Hartog L, Kant A, Van Roozelaar DJ (1990) Antigenic domains on the peplomer protein of avian infectious bronchitis virus: correlation with biological functions. J Gen Virol 71: 1929–1935Google Scholar
  21. 21.
    Koolen MJM, Borst MAJ, Horzinek MC, Spaan WJM (1990) Immunogenic peptide comprising a mouse hepatitis virus A59 B-cell epitope and an influenza virus T-cell epitope protects against lethal infection. J Virol 64: 6270–6273Google Scholar
  22. 22.
    Kusters JG, Jager EJ, Niesters HGM, Van Der Zeijst BAM (1990) Sequence evidence of RNA recombination in field isolates of avian coronavirus infectious bronchitis virus. Vaccine 8: 605–608Google Scholar
  23. 23.
    Kusters JG, Jager EJ, Lenstra JA, Koch G, Posthumus WPA, Meloen RH, Van Der Zeijst BAM (1989) Analysis of an immunodominant region of infectious bronchitis virus. J Immunol 143: 2692–2698Google Scholar
  24. 24.
    Lenstra JA, Kusters JG, Koch G, Van Der Zeijst BAM (1989) Antigenicity of the peplomer protein of infectious bronchitis virus. Mol Immunol 26: 7–15Google Scholar
  25. 25.
    Mobley J, Evans G, Dailey MO, Perlman S (1992) Immune response to a murine coronavirus: identification of a homing receptor-negative CD4+ T cell subset that responds to viral glycoproteins. Virology 187: 443–452Google Scholar
  26. 26.
    Mockett APA (1985) Envelope proteins of avian infectious bronchitis virus: purification and biological properties. J Virol Methods 12: 271–278Google Scholar
  27. 27.
    Mockett APA, Cavanagh D, Brown TDK (1984) Monoclonal antibodies to the S1 spike and membrane proteins of avian infectious bronchitis coronavirus strain Massachusetts M41. J Gen Virol 65: 2281–2286Google Scholar
  28. 28.
    Perlman S, Schelper R, Ries D (1987) Maternal antibody-modulated MHV-JHM infection in C57BL/6 and Balb/c mice. Adv Exp Med Biol 218: 297–305Google Scholar
  29. 29.
    Spaan WJM (1990) Progress towards a coronavirus recombinant DNA vaccine. In: Cavanagh D, Brown TDK (Eds) Coronaviruses and their diseases. Plenum Press, New York, pp 201–203Google Scholar
  30. 30.
    Sturman LS, Ricard CS, Holmes KV (1985) Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: activation of cell-fusing activity of virions by trypsin and separation of two different 90 K cleavage fragments. J Virol 56: 904–911Google Scholar
  31. 31.
    Sussman MA, Shubin RA, Kyuwa S, Stohlman SA (1989) T-cell-mediated clearance of mouse hepatitis virus strain JHM from the central nervous system. J Virol 63: 3051–3056Google Scholar
  32. 32.
    Talbot PJ, Dionne G, Lacroix M (1988) Vaccination against lethal coronavirus-induced encephalitis with a synthetic decapeptide homologous to a domain in the predicted peplomer stalk. J Virol 62: 3032–3036Google Scholar
  33. 33.
    Vennema H, De Groot RJ, Harbour DA, Dalderup M, Gruffydd-Jones T, Horzinek MC, Spaan WJM (1990) Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization. J Virol 64: 1407–1409Google Scholar
  34. 34.
    Vennema H, De Groot RJ, Harbour DA, Horzinek MC, Spaan WJM (1991) Primary structure of the membrane and nucleocapsid protein genes of feline infectious peritonitis virus and immunogenicity of recombinant vaccinia viruses in kittens. Virology 181: 327–335Google Scholar
  35. 35.
    Wang L, Junker D, Collisson EW (1993) Evidence of natural recombination within the S1 gene of infectious bronchitis virus. Virology 192: 710–716Google Scholar
  36. 36.
    Wesseling JG, Godeke G-J, Schijns VECJ, Prevec L, Graham FL, Horzinek MC, Rottier PJM (1993) Mouse hepatitis virus spike and nucleocapsid proteins expressed by adenovirus vectors protect mice against a lethal infection. J Gen Virol 74: 2061–2069Google Scholar
  37. 37.
    Yamaguchi K, Goti N, Kyuwa S, Hayami M, Toyoda Y (1991) Protection of mice from a lethal coronavirus infection in the central nervous system by adoptive transfer of virus-specific T cell clones. J Neuroimmunol 32: 1–9Google Scholar

Copyright information

© Springer-Verlag 1994

Authors and Affiliations

  • J. Ignjatovic
    • 1
  • L. Galli
    • 1
  1. 1.Animal Health Research LaboratoryCSIRO Division of Animal HealthParkvilleAustralia

Personalised recommendations